ReviewAntibiotics (Basel, Switzerland)2019
The Clinical and Economic Impact of Antibiotic Resistance in China: A Systematic Review and Meta-Analysis.
Review in Antibiotics (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Risk factors for antibiotic resistance development in healthcare settings in China: a systematic review.Epidemiology and infection · 2021Pooled it
- Prevalence of extended-spectrum β-lactamase and carbapenemase-producing Escherichia coli from patients, cattle, and environmental sources in northwest Amhara, Ethiopia: a one health approach.BMC microbiology · 2026Article
- Prevalence, antibiotic resistance, resistance and virulence determinants ofOne health (Amsterdam, Netherlands) · 2025Review
- Regulating antimicrobial resistance in the environment: analysis of Thailand legal framework and areas for reinforcement.Science in One Health · 2025Article
- Article
- Genomic epidemiology and antimicrobial resistance ofFrontiers in cellular and infection microbiology · 2024Article
- Nurses' engagement in antimicrobial stewardship and its influencing factors: A cross-sectional study.International journal of nursing sciences · 2024Article
- Limiting the Spread of Multidrug-Resistant Bacteria in Low-to-Middle-Income Countries: One Size Does Not Fit All.Pathogens (Basel, Switzerland) · 2023Review
- Association between antibiotic resistance and increasing ambient temperature in China: An ecological study with nationwide panel data.The Lancet regional health. Western Pacific · 2023Article
- Epidemiology and Traits of Mobile Colistin Resistance (Microorganisms · 2022Review
- Recombinant human β-defensin130 inhibited the growth of foodborne bacteria through membrane disruption and exerted anti-inflammatory activity.Food science and biotechnology · 2022Article
- Antibiofilm property and multiple action of peptide PEW300 againstFrontiers in microbiology · 2022Article
- Nationwide Surveillance and Molecular Characterization of Critically Drug-Resistant Gram-Negative Bacteria: Results of the Research University Network Thailand Study.Antimicrobial agents and chemotherapy · 2021Article
- Socioeconomic Factors Contributing to Antibiotic Resistance in China: A Panel Data Analysis.Antibiotics (Basel, Switzerland) · 2021Article
- The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018-2019: an interrupted time-series analysis.BMC health services research · 2021Article
- The General Population's Inappropriate Behaviors and Misunderstanding of Antibiotic Use in China: A Systematic Review and Meta-Analysis.Antibiotics (Basel, Switzerland) · 2021Review
- Selective toxicity of antibacterial agents-still a valid concept or do we miss chances and ignore risks?Infection · 2021Review
- Article
- Clinical Molecular and Genomic Epidemiology ofFrontiers in microbiology · 2021Article
- Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused byAntibiotics (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Antibiotic resistance (ABR) is one of the biggest threats to global health, especially in China. This study aims to analyze the published literature on the clinical and economic impact of ABR or multi-drug resistant (MDR) bacteria compared to susceptible bacteria or non-infection, in mainland China. English and Chinese databases were searched to identify relevant studies evaluating mortality, hospital stay, and hospital costs of ABR. A meta-analysis of mortality was performed using a random effects model. The costs were converted into 2015 United States (US) dollars. Of 13,693 studies identified, 44 eligible studies were included. Twenty-nine investigated the impact of ABR on hospital mortality, 37 were focused on hospital stay, and 21 on hospital costs. Patients with ABR were associated with a greater risk of overall mortality compared to those with susceptibility or those without infection (odds ratio: 2.67 and 3.29, 95% confidence interval: 2.18-3.26 and 1.71-6.33,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.